Endocrinologia, Diabetes y Nutricion, 64 (5), 278280
National Institutes of Health: Office of Dietary Supplements
The science behind GLP-1 receptor desensitization Before you can reset something, you need to understand what changed
Use of glucagon-like peptide 1 receptor agonists and risk of thyroid cancer: Scandinavian cohort study
Retatrutide builds on that concept by incorporating an additional receptor target without abandoning the dual-incretin foundation
Drug Interactions: The concomitant use of XIGDUO XR with specific drugs may increase the risk of metformin-associated lactic acidosis: those that impair renal function, result in significant hemodynamic change, interfere with acid-base balance or increase metformin accumulation (e.g., cationic drugs) [see Drug Interactions (7)]